The 10-second takeaway
For the quarter ended March 31 (Q2), Female Health beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased significantly. GAAP earnings per share expanded significantly.
Gross margins were steady, operating margins grew, net margins expanded.
Female Health reported revenue of $9.5 million. The two analysts polled by S&P Capital IQ looked for sales of $8.9 million on the same basis. GAAP reported sales were 21% higher than the prior-year quarter's $7.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.12. The two earnings estimates compiled by S&P Capital IQ predicted $0.09 per share. GAAP EPS of $0.12 for Q2 were 71% higher than the prior-year quarter's $0.07 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 58.2%, much about the same as the prior-year quarter. Operating margin was 35.4%, 780 basis points better than the prior-year quarter. Net margin was 36.8%, much better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $9.6 million. On the bottom line, the average EPS estimate is $0.10.
Next year's average estimate for revenue is $38.9 million. The average EPS estimate is $0.54.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 332 members out of 342 rating the stock outperform, and 10 members rating it underperform. Among 66 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 66 give Female Health a green thumbs-up, and give it a red thumbs-down.
Looking for alternatives to Female Health? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Female Health to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.